Patient Input Needed for Recurrent Ov... - SHARE Ovarian Can...

SHARE Ovarian Cancer Support

2,784 members991 posts

Patient Input Needed for Recurrent Ovarian Cancer Research

SBlau profile image
SBlauPartner
1 Reply

I'm sharing information about a survey being conducted in the U.S. by Trinity Partners. This research is not affiliated with SHARE. Check out the info below and decide if you would like to join the survey.

Patient Input Needed for Ovarian Cancer Research

Do you live with Recurrent Ovarian Cancer? If so, your input is valued. Researchers would like to better understand your experiences living with recurrent ovarian cancer.

What is needed from me?

You would participate in a short online survey to share your story: your experiences with doctors, treatments you have been prescribed and/or are currently taking, and preferences for treatments for ovarian cancer. We are looking to survey US-based ovarian cancer patients 18+ years old. You will be asked a few questions to make sure you qualify for the survey. If you qualify, the entire survey will take about 30 minutes to complete but you can take as much time as you need to complete it.

You will be compensated $50 for your time after completion of the survey.

Your participation is confidential and anonymous. This study is being conducted by Trinity Partners, a healthcare research and consulting company that is gathering the data for ovarian cancer researchers. This is not a sales effort of any kind and your contact information will not be shared with anyone.

How can I take part?

If you think you may be eligible for this research, please visit: ovariancancersurvey.com for instructions on how to get started. You do not have to take part in this survey and you may stop participating at any time. There are no costs associated with your participation and all personal information remains confidential.

This study has been reviewed by The University of Mississippi’s Institutional Review Board (IRB). If you have any questions, concerns, or reports regarding your rights or the rights of participants of research, please contact the IRB at (662) 915-7482 or irb@olemiss.edu.

Written by
SBlau profile image
SBlau
Partner
To view profiles and participate in discussions please or .
1 Reply
carolleigh profile image
carolleigh

Very interesting survey. I took it then made a mistake, hit the back button and lost everything, so beware. It was a lot of work...but I learned a lot by taking it.

Not what you're looking for?

You may also like...

ONIONS ‘could stop the spread of deadly ovarian cancer’

Hi everyone, just found this interesting article about the recent research conducted by the...

Zejula Granted FDA Approval for Ovarian Cancer

Below is an article from Cure.com about Zejula, the new drug recently approved by the FDA for...

Ask an Ovarian Cancer Expert Anything: Announcing Our First AMA!

On June 14, all members of the SHARE Ovarian Cancer Support community will be able to chat with...

Ovarian cancer drug delivers ‘very promising’ results in early trial

Here's an article about a promising new drug for women with advanced ovarian cancer:...

Ovarian Cancer Screening Tests?

Did any of you hear that the FDA recently issued a warning against the use of products marketed as...